Bioventus Inc. (BVS)

AI Score

Unlock

8.22

-0.93 (-10.16%)

At close: Apr 04, 2025, 12:47 PM

Bioventus Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 1999
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Jan 1, 2000
Revenue	573.28M	512.35M	512.12M	430.9M	321.16M	340.14M	319.18M	292.06M	274.5M	253.65M	242.89M	232.38M	64.77M
Cost of Revenue	n/a	184.15M	181.04M	128.19M	87.64M	90.94M	84.17M	92.1M	91.39M	74.34M	74.61M	71.37M	18.97M
Gross Profit	573.28M	328.19M	331.08M	302.71M	233.52M	249.21M	235.01M	199.96M	183.11M	179.31M	168.28M	161M	45.81M
Operating Income	n/a	-81.72M	-35.68M	17.72M	21.24M	31.19M	25.5M	27.02M	14.89M	-16.59M	20K	-8.07M	-35.67M
Interest Income	n/a	n/a	25.8M	1.11M	9.75M	21.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-49.13M	-121.11M	-263.9M	7.62M	15.91M	9.69M	6.11M	8.66M	-5.65M	-31.97M	-11.35M	-20.24M	-39.09M
Net Income	-49.13M	-156.23M	-213.39M	9.59M	16.41M	6.85M	-12.21M	-1.64M	-17.95M	-34.11M	-12.9M	-22.37M	-39.22M
Selling & General & Admin	n/a	303.88M	332.61M	254.25M	193.08M	198.47M	191.67M	164.84M	160.32M	148.44M	147.06M	150.37M	76.82M
Research & Development	n/a	13.45M	25.94M	19.04M	11.2M	11.05M	8.1M	8.1M	7.9M	14.75M	9.46M	10.94M	4.67M
Other Expenses	n/a	92.59M	21.15M	8.36M	7.44M	7.91M	-226K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	n/a	409.92M	379.7M	281.65M	211.72M	217.44M	207.64M	172.94M	168.22M	173.76M	165.49M	169.07M	81.48M
Interest Expense	-38.79M	40.68M	25.8M	1.11M	9.75M	21.58M	19.17M	18.9M	15.94M	14.23M	11.97M	11.46M	3.64M
Selling & Marketing Expenses	n/a	3.85M	5.2M	3.87M	2.77M	2.35M	n/a	n/a	n/a	n/a	n/a	n/a	42.9M
Cost & Expenses	n/a	594.07M	560.74M	409.85M	299.36M	308.37M	291.81M	265.04M	259.61M	248.1M	240.1M	240.44M	100.45M
Income Tax Expense	-49.13M	85K	-50.51M	-1.97M	1.19M	1.58M	1.66M	-785K	1.09M	2.14M	1.55M	2.13M	132K
Shares Outstanding (Basic)	65.36M	62.65M	61.39M	59.55M	56.83M	56.83M	55.63M	56.83M	56.83M	55.63M	55.63M	55.63M	55.63M
Shares Outstanding (Diluted)	65.36M	62.65M	61.39M	59.55M	56.83M	56.83M	55.63M	56.83M	56.83M	55.63M	55.63M	55.63M	55.63M
EPS (Basic)	-0.75	-2.49	-3.48	0.16	0.29	0.12	-0.22	-0.03	-0.32	-0.61	-0.23	-0.4	-0.71
EPS (Diluted)	-0.75	-2.49	-3.48	0.16	0.29	0.12	-0.22	-0.03	-0.32	-0.61	-0.23	-0.4	-0.71
EBITDA	-49.55M	-23.07M	-109.2M	51.81M	50.44M	61.58M	54.52M	59.32M	48.65M	15.18M	34.42M	15.68M	-16.48M
EBIT	n/a	-80.44M	-177M	13.12M	25.66M	31.27M	25.28M	27.55M	10.28M	-17.74M	616K	-8.78M	-35.45M
Depreciation & Amortization	-49.55M	57.37M	61.4M	38.68M	28.64M	30.32M	29.24M	32.29M	33.76M	33.08M	28.82M	24.46M	18.97M